Multidisciplinary Journal of Science and Technology

INCIDENCE, RISK FACTORS, AND PREVENTION OF VULVAR CANCER IN WOMEN

Avazova Gulshoda

Masters of General Oncology Tashkent State Medical University

Ziyodullaeva Marvarid

Masters of General Oncology Tashkent State Medical University

Keywords: vulvar cancer, incidence, risk factors, prevention, HPV, vulvar intraepithelial neoplasia, lichen sclerosus, women’s health.

---

Abstract

Vulvar cancer is a relatively uncommon malignancy, yet it carries substantial morbidity because it affects a sensitive anatomical site, is frequently diagnosed at later stages, and often requires treatment that can be physically and psychologically burdensome. Epidemiologic evidence suggests that vulvar cancer incidence varies widely across regions and age groups, reflecting differences in population aging, human papillomavirus (HPV) exposure, screening practices for precursor lesions, and the prevalence of chronic vulvar inflammatory conditions. Contemporary understanding recognizes two major etiologic pathways: (1) HPV-associated disease, often preceded by usual-type vulvar intraepithelial neoplasia (uVIN/HSIL) and more common in younger women; and (2) HPV-independent disease, frequently linked to chronic dermatoses such as lichen sclerosus and preceded by differentiated VIN, typically occurring in older women and associated with poorer outcomes. Prevention therefore requires a dual strategy: primary prevention by HPV vaccination and risk-reduction behaviors, and secondary prevention through early recognition and treatment of precursor lesions and prompt evaluation of persistent vulvar symptoms. This article synthesizes current evidence on global incidence patterns, established and emerging risk factors, and practical prevention frameworks. Emphasis is placed on integrating HPV immunization, targeted education, clinician vigilance for chronic vulvar symptoms, and proactive management of vulvar dermatoses to reduce disease burden and improve women’s health outcomes.

---

References

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA: A Cancer Journal for Clinicians. – 2021. – Vol. 71, No. 3. – P. 209–249.

2. Hacker N.F., Eifel P.J., van der Velden J. Cancer of the vulva // International Journal of Gynecology & Obstetrics. – 2015. – Vol. 131. – Suppl. 2. – P. S76–S83.

3. de Sanjosé S., Alemany L., Ordi J., et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva // European Journal of Cancer. – 2013. – Vol. 49, No. 16. – P. 3450–3461.

4. Preti M., Scurry J., Marchitelli C.E., Micheletti L. Vulvar intraepithelial neoplasia // Best Practice & Research Clinical Obstetrics & Gynaecology. – 2014. – Vol. 28, No. 7. – P. 1051–1062.

5. Halec G., Alemany L., Lloveras B., et al. Pathogenic role of human papillomavirus in vulvar cancer: A worldwide study // Journal of the National Cancer Institute. – 2017. – Vol. 109, No. 6. – djw272.

6. Centers for Disease Control and Prevention (CDC). HPV Vaccination: What Everyone Should Know. – Atlanta: CDC, 2023. – URL: https://www.cdc.gov/hpv (murojaat sanasi: 2025).